GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Price (Quote)

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $3.02 $6.17 Friday, 27th May 2022 CATB stock ended at $3.36. This is 6.16% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 6.65% from a day low at $3.16 to a day high of $3.37.
90 days $3.02 $7.25
52 weeks $1.20 $10.26

Historical Catabasis Pharmaceuticals prices

Date Open High Low Close Volume
2019-08-19 $6.10 $6.72 $6.03 $6.34 69 633
2019-08-16 $6.15 $6.16 $6.02 $6.08 28 121
2019-08-15 $6.15 $6.21 $5.87 $6.05 49 836
2019-08-14 $6.31 $6.31 $5.97 $6.10 54 501
2019-08-13 $6.40 $6.45 $6.31 $6.41 26 872
2019-08-12 $6.55 $6.55 $6.33 $6.39 24 191
2019-08-09 $6.60 $6.64 $6.41 $6.56 19 468
2019-08-08 $6.65 $6.71 $6.51 $6.61 35 136
2019-08-07 $6.59 $6.65 $6.49 $6.49 11 649
2019-08-06 $6.75 $6.76 $6.31 $6.65 33 118
2019-08-05 $6.81 $6.81 $6.55 $6.65 59 807
2019-08-02 $6.84 $6.93 $6.72 $6.91 42 099
2019-08-01 $7.09 $7.22 $6.80 $6.83 61 042
2019-07-31 $7.37 $7.41 $7.08 $7.08 23 148
2019-07-30 $7.15 $7.47 $7.02 $7.39 33 248
2019-07-29 $6.83 $7.20 $6.83 $7.14 41 807
2019-07-26 $6.73 $6.89 $6.70 $6.82 14 903
2019-07-25 $7.03 $7.12 $6.72 $6.81 34 820
2019-07-24 $7.06 $7.17 $6.90 $7.10 19 785
2019-07-23 $7.15 $7.24 $6.87 $7.10 37 375
2019-07-22 $7.12 $7.29 $7.10 $7.14 45 943
2019-07-19 $7.20 $7.44 $7.08 $7.11 42 282
2019-07-18 $7.45 $7.51 $7.21 $7.31 36 968
2019-07-17 $7.50 $7.50 $7.30 $7.41 21 899
2019-07-16 $7.43 $7.68 $7.38 $7.43 41 034
Click to get the best stock tips daily for free!

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... CATB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT